Safety and Immune Responses to Attenuated Salmonella enterica Serovar Typhi Oral Live Vector Vaccines Expressing Tetanus Toxin Fragment C

This publication has 17 references indexed in Scilit:

• Phase 2 Clinical Trial of AttenuatedSalmonella entericaSerovar Typhi Oral Live Vector Vaccine CVD 908-htrAin U.S. Volunteers
  Infection and Immunity, 2000
• In Vivo Characterization of the Murine Intranasal Model for Assessing the Immunogenicity of AttenuatedSalmonella entericaSerovar Typhi Strains as Live Mucosal Vaccines and as Live Vectors
  Infection and Immunity, 2000
• Optimism over vaccines administered via mucosal surfaces
  The Lancet, 1998
• A murine model of intranasal immunization to assess the immunogenicity of attenuated Salmonella typhi live vector vaccines in stimulating serum antibody responses to expressed foreign antigens
  Vaccine, 1997
• Expression of fragment C of tetanus toxin fused to a carboxyl-terminal fragment of diphtheria toxin in Salmonella typhi CVD 908 vaccine strain
  Vaccine, 1995
• Cytotoxic T lymphocytes after oral immunization with attenuated vaccine strains of Salmonella typhi in humans.
  The Journal of Immunology, 1995
• Use of the nirB Promoter to Direct the Stable Expression of Heterologous Antigens in Salmonella Oral Vaccine Strains: Development of a Single–Dose Oral Tetanus Vaccine
  Nature Biotechnology, 1992
• EFFECT OF PRIMING WITH CARRIER ON RESPONSE TO CONJUGATE VACCINE
  The Lancet, 1989
• Safety, infectivity, immunogenicity, and in vivo stability of two attenuated auxotrophic mutant strains of Salmonella typhi, 541Ty and 543Ty, as live oral vaccines in humans.
  Journal of Clinical Investigation, 1987
• Demonstration of Specific IgA in Human Feces after Immunization with Live Ty21a Salmonella typhi Vaccine
  The Journal of Infectious Diseases, 1985